Processing your payment...
Please do not close your browser.

Heparin Market - Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin

08 Jan, 2020 | 122 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Registering a CAGR of 3.5% over the forecast period, the Heparin market is anticipated to reach the market value of US$ 1221.5 million in the year 2027 from US$ 1063.4 million in the year 2021.



Heparin Market Overview:



Heparin is a glycosaminoglycan that occurs naturally in the body. Heparin is an anticoagulant that is used in medicine to prevent blood clots from forming. It is used to treat unstable angina and heart attacks in particular. Heparin is also used to treat deep vein thrombosis, acute coronary syndrome, atrial fibrillation, and pulmonary embolism, as well as hemofiltration during cardiac surgery and cardiopulmonary bypass. The rising prevalence of chronic diseases such as cancer, heart disease, stroke, diabetes, and arthritis would improve global market statistics. According to the Centers for Disease Control (CDC), roughly 659,000 persons in the United States will die from a heart-related condition in 2021, accounting for one out of every four deaths in the country. Increased demand for heparin has resulted from a growth in the number of individuals suffering from cardiovascular problems, moving the market landscape forward. Furthermore, the increased prevalence of chronic diseases among middle-aged and elderly people will accelerate market projections.





Heparin Market Growth Drivers




  • Growing prevalence of chronic diseases

  • High demand for anticoagulants products

  • Rising geriatric population across the globe



Industry News and Updates



April 21, 2021: Fresenius Kabi Introduces Low Concentration Heparin Sodium in Sodium Chloride Injection in Ready-to-Use Freeflex® Bags-- 

Fresenius Kabi announced today it has introduced in the United States two new presentations of Heparin Sodium in convenient, ready-to-administer Freeflex® IV bags. Fresenius Kabi Heparin Sodium in Sodium Chloride injection at a concentration of 2 USP units per mL is indicated as an anticoagulant to maintain catheter patency.



April 24, 2019: B. Braun launches the First FDA-Approved Heparin Sodium Prefilled Syringe with attached safety needle-- 

B. Braun Medical Inc. announced today the launch of its Heparin Sodium Injection, USP - the first Heparin 5,000 USP Unit / 0.5 mL prefilled syringe with attached safety needle for subcutaneous and intravenous use in the United States.



What are the major Applications, Types, and Regions for Heparin Market?



By Type, Heparin Market has been segmented into 




  • Heparin Sodium

  • Heparin Calcium

  • Other



By Applications, Heparin Market has been segmented into 




  • UFH

  • LMWH



Heparin Market Regional Analysis:



The report offers an in-depth assessment of the growth and other aspects of the Heparin Market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, and Latin America.



Due to the existence of important market participants such as Pfizer and Amphastar, among others, the North American heparin market was valued at over 777.5 million in 2021. Furthermore, the rising frequency of chronic diseases in North American countries is likely to promote regional market growth. According to the Centers for Disease Control and Prevention (CDC), between 5% to 8% of the population in the United States has one of several genetic risk factors, commonly known as hereditary thrombophilia, in which a genetic flaw increases the risk of thrombosis. If a result, as the risk of thrombosis rises, so will the need for heparin, boosting the North American market.



Heparin Market highlights the potential growth opportunities in upcoming years while reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects in the global market. The Global Heparin Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. This Research Study compares the markets of Pre COVID-19 and Post COVID-19 with the impact of COVID-19 on the regional economy.



What is our Heparin Market report scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 3.5% over the forecast period (2022-2027)



By Type




  • Heparin Sodium

  • Heparin Calcium

  • Other



By Application




  • UFH

  • LMWH



By Companies



Opocrin S.p.A. (Formigine, Italy), Baxter (Deerfield, U.S.), Pfizer Inc. (New York, U.S.), Bioiberica S.A.U. (Barcelona, Spain), Fresenius SE & Co. KGaA (Bad Homburg, Germany), Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China), B. Braun Melsungen AG (Melsungen, Germany), Dr. Reddy’s Laboratories Ltd. (Hyderabad, India), LEO Pharma A/S (Ballerup, Denmark), Aspen Holdings (Durban, South Africa), Hepalink, Changshan Pharm, Qianhong Bio-pharma, King-friend Biochemical Pharmaceutical, Bioibérica, Dongcheng Biochemicals, Jiulong Biochemicals, Tiandong, Xinbai, Yino Pharma, Deebio



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



122



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key Takeaways from this Heparin Report




  • Evaluate Heparin market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level - for product types, end-use applications, and by different industry verticals.

  • Understand the different dynamics influencing the market - key driving factors, challenges, and hidden opportunities.

  • Get in-depth insights on your competitor's performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT, and more.

  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.

  • Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Heparin market entropy - M&As, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the supply-demand gaps, import-export statistics, and regulatory landscape for more than the top 20 countries globally for the market.



Frequently Asked Questions



What is the growth rate of Heparin Market?



The Heparin Market is growing at a CAGR of 3.5% over the next 5 years.



Who are the key players in Heparin Market?



Opocrin S.p.A. (Formigine, Italy), Baxter (Deerfield, U.S.), Pfizer Inc. (New York, U.S.), Bioiberica S.A.U. (Barcelona, Spain), Fresenius SE & Co. KGaA (Bad Homburg, Germany), Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China), B. Braun Melsungen AG (Melsungen, Germany), Dr. Reddy’s Laboratories Ltd. (Hyderabad, India), LEO Pharma A/S (Ballerup, Denmark), Aspen Holdings (Durban, South Africa), Hepalink, Changshan Pharm, Qianhong Bio-pharma, King-friend Biochemical Pharmaceutical, Bioibérica, Dongcheng Biochemicals, Jiulong Biochemicals, Tiandong, Xinbai, Yino Pharma, Deebio



What are the significant types of Heparin Market?



Heparin Sodium, Heparin Calcium, Other



What are the major end-use applications of Heparin Market?



UFH, LMWH



On the basis of application, Which segment is likely to hold the major share in the Heparin Market?



LMWH segment to hold the largest share in Heparin market



All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL HEPARIN MARKET BY TYPE

    3. GLOBAL HEPARIN MARKET BY APPLICTAION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR HEPARIN



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. HEPARIN GROWTH

      2. APPLICATION OF HEPARIN



    4. IMPACT OF COVID 19



  5. GLOBAL HEPARIN MARKET, BY TYPE

    1. INTRODUCTION

    2. HEPARIN SODIUM

    3. HEPARIN CALCIUM

    4. OTHER          



  6. GLOBAL HEPARIN MARKET, BY APPLICATION

    1. INTRODUCTION

    2. UFH

    3. LMWH



  7. GLOBAL HEPARIN MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. HEPALINK

      2. CHANGSHAN PHARM

      3. QIANHONG BIO-PHARMA

      4. OPOCRIN

      5. PFIZER

      6. ASPEN OSS

      7. KING-FRIEND BIOCHEMICAL PHARMACEUTICAL

      8. BIOIB-RICA

      9. DONGCHENG BIOCHEMICALS

      10. JIULONG BIOCHEMICALS

      11. TIANDONG

      12. XINBAI

      13. YINO PHARMA

      14. DEEBIO





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • 3M
  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony